T1	Participants 320 338	Caucasian patients
T2	Participants 372 376	CAHB
T3	Participants 344 370	chronic active hepatitis B
T4	Participants 623 700	10 Chinese patients with histologically proven CAHB and seven healthy Chinese
T5	Participants 701 713	individuals.
T6	Participants 2174 2195	Chinese CAHB patients
T7	Participants 2224 2253	Caucasian patients with CAHB,
